Cell Biology

Hamilton Thorne to Present at the Baird 2020 Global Healthcare Conference – GlobeNewswire

BEVERLY, Mass. and TORONTO, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and CEO of Hamilton Thorne Ltd., will deliver a virtual presentation at the upcomingBaird 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 3:45 EDT. Mr. Wolf will also be available for virtual one-on-one meetings during the conference.

About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thornes customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Neither the TSX Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Read more from the original source:
Hamilton Thorne to Present at the Baird 2020 Global Healthcare Conference - GlobeNewswire

Cell Biology

How Plants Close the Door on Infection – Technology Networks

Plants have a unique ability to safeguard themselves against pathogens by closing their poresbut until now, no one knew quite how they did it. Scientists have known that a flood of calcium into the cells surrounding the pores triggers them to close, but how the calcium entered the cells was unclear.

A new study by an international team including University of Maryland scientists reveals that a protein called OSCA1.3 forms a channel that leaks calcium into the cells surrounding a plants pores, and they determined that a known immune system protein triggers the process.

The findings are a major step toward understanding the defense mechanisms plants use to resist infection, which could eventually lead to healthier, more resistant and more productive crops. The research paper was published on August 26, 2020 in the journal Nature.

This is a major advance, because a substantial part of the worlds food generated by agriculture is lost to pathogens, and we now know the molecular mechanism behind one of the first and most relevant signals for plant immune response to pathogensthe calcium burst after infection, said Jos Feij, a professor of cell biology and molecular genetics at UMD and co-author of the study. Finding the mechanism associated with this calcium channel allows further research into its regulation, which will improve our understanding of the way in which the channel activity modulates and, eventually, boosts the immune reaction of plants to pathogens.

Plant porescalled stomataare encircled by two guard cells, which respond to calcium signals that tell the cells to expand or contract and trigger innate immune signals, initiating the plants defense response. Because calcium cannot pass directly through the guard cell membranes, scientists knew a calcium channel had to be at work. But they didnt know which protein acted as the calcium channel.

To find this protein, the studys lead author, Cyril Zipfel, a professor of molecular and cellular plant physiology at the University of Zurich and Senior Group Leader at The Sainsbury Laboratory in Norwich, searched for proteins that would be modified by another protein named BIK1, which genetic studies and bioassays identified as a necessary component of the immune calcium response in plants.

When exposed to BIK1, one protein called OSCA1.3 transformed in a very specific way that suggested it could be a calcium channel for plants. OSCA1.3 is a member of a widespread family of proteins known to exist as ion channels in many organisms, including humans, and it seems to be specifically activated upon detection of pathogens.

To determine if OSCA1.3 was, in fact, the calcium channel he was looking for, Zipfel's team reached out to Feij, who is also an affiliate professor in the College of Agriculture and Natural Resources at UMD and is well known for identifying and characterizing novel ion channels and signaling mechanisms in plants. Erwan Michard, a visiting assistant research scientist in Feijs lab and co-author of the paper, conducted experiments that revealed Zipfels BIK1 bait triggers OSCA1.3 to open up a calcium channel into a cell and also explained the mechanism for how it happens.

BIK1 only activates when plants get infected with a pathogen, which suggests that OSCA1.3 opens a calcium channel to close stomata as a defensive, immune system response to pathogens.

This is a perfect example of how a collaborative effort between labs with different expertise can bring about important conclusions that would be difficult on solo efforts, Feij said. This fundamental knowledge is badly needed to inform ecology and agriculture on how the biome will react to the climatic changes that our planet is going through.

Feij will now incorporate this new knowledge of the OSCA1.3 calcium channel into other areas of research in his lab, which is working to understand how the mineral calcium was co-opted through evolution by all living organisms to serve as a signaling device for information about stressors from infection to climate change.

Despite the physiological and ecological relevance of stomatal closure, the identity of some of the key components mediating this closure were still unknown, Zipfel said. The identification of OSCA1.3 now fills one of these important gaps. In the context of plant immunity this work is particularly apt in 2020, the UN International Year of Plant Health.

ReferenceThor, K., Jiang, S., Michard, E. et al. The calcium-permeable channel OSCA1.3 regulates plant stomatal immunity. Nature (2020). https://doi.org/10.1038/s41586-020-2702-1

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

View original post here:
How Plants Close the Door on Infection - Technology Networks

Cell Biology

The Merging Of Human And Machine. Two Frontiers Of Emerging Technologies – Forbes

Molecular Science as a Scientific Field of Study

An amazing aspect of living in The Fourth Industrial Era is that we are at a new inflection point in bringing emerging technologies to life. We are in an era of scientific breakthroughs that will change the way of life as we currently know it. While there are many technological areas of fascination for me, the meshing of biology with machine is one of the most intriguing. It fuses many elements of technologies especially artificial intelligence and pervasive computing. I have highlighted two frontiers of mind-bending developments that are on the horizon, Neuromorphic technologies, and human-machine biology.

Neuromorphic Technologies

Human computer interaction (HCI) was an area of research that started in the 1980s and has come a long way in a short period of time. HCI was the foundation for what we call neuromorphic computing, the integration of systems containing electronic analog circuits to mimic neuro-biological architectures present in the biological nervous system.

In 2018, in research funded by the Defense Advanced Projects Agency (DARPA) demonstrated that a person with a brain chip could pilot a swarm of drones using signals from the brain. There have been a variety of studies and experiments since then, and no doubt science combining neural networks and artificial intelligence is on a path to enhance and even upgrade human cognition capabilities.

Recently, a research team from Columbia University tested the convergence of neural networks. They combined brain implants, artificial intelligence, and a speech synthesizer to translate brain activity into recognizable robotic words. The implications of this neuromorphic technology are mind-boggling, including allowing paralyzed people the ability to communicate and the potential to read human thoughts via cognitive imaging. (1)

A Frontiers in Science publication involving the collaboration of academia, institutes, and scientistssummed up the promise of the human computer interface, They concluded that We can imagine the possibilities of what may come next with the human brain machine interface. A human B/CI system mediated by neural nanorobotics could empower individuals with instantaneous access to all cumulative human knowledge available in the cloud and significantly improve human learning capacities and intelligence. Further, it might transition totally immersive virtual and augmented realities to unprecedented levels, allowing for more meaningful experiences and fuller/richer expression for, and between, users. These enhancements may assist humanity to adapt emergent artificial intelligence systems as human-augmentation technologies, facilitating the mitigation of new challenges to the human species. (2)

This week, Elon Musk announced that his neuroscience company, NeuraLink, created to develop cranial computers that can rapidly upload and process information, will demonstrate their lasts device that would let humans control computers with their mind via surgically implant electrodes. Linking brains to computers is no longer the stuff of science fiction.

Human-Machine Biology

The field of human and biological applications has many applications for medical science. This includes precision medicine, genome sequencing and gene editing (CRISPR), cellular implants, and wearables that can be implanted in the human body The medical community is experimenting with delivering nano-scale drugs (including anti-biotic smart bombs to target specific strains of bacteria. Soon they will be able to implant devices such as bionic eyes and bionic kidneys, or artificially grown and regenerated human organs. Succinctly, we are on the cusp of significantly upgrading the human ecosystem. It is indeed revolutionary.

This revolution will expand exponentially in the next few years. We will see the merging of artificial circuitries withsignaturesof our biological intelligence, retrieved in the form of electric, magnetic, and mechanical transductions. Retrieving these signatures will be like taking pieces of cells (including our tissue-resident stem cells) in the form of code for their healthy, diseased or healing states, or a code for their ability to differentiate into all the mature cells of our body. This process will represent an unprecedented form of taking a glimpse of human identity. (3)

In the future biocomputers may be able to store on the DNA of living cells. This technology could store almost unlimited amounts of data and allow the biocomputers to perform complex calculations beyond our current capabilities.

Researchers at the Technion have already created a biological computer, constructed within a bacterial cell. developed a complex biocomputer, that is, a programmed biological system that fulfills complex tasks. The research by Ph.D. student Natalia Barger and Assistant Professor Ramez Daniel, head of the Synthetic Biology and Bioelectronics Lab at the Technion's Faculty of Biomedical Engineering, was published in September 2019 in the journalNucleic Acids Research(NAR) "We built a kind ofbiological computerin the livingcells. In this computer, as in regular computers, circuits carry out complicated calculations," said Barger. "Only here, these circuits are genetic, not electronic, and information are carried by proteins and not electrons." (4)

The Human-machine synergies now being explored offer us a glimpse into the not so distant future. Clearly, from the perspective of human augmentation, the promise is exciting. The future will also encompass moral issues to address such as containing super artificial intelligence, ensuring cyborg rights, and a whole host of other related ethical topics. It is evident is that human-machine interface will help pave our futures. How we harness it for good should be our focus. Perhaps that will be what the Fifth Industrial Revolution will codify.

Footnote:this past year I designed and wrote a graduate course for Georgetown University called Disruptive Technologies and Organizational Management. I am now enjoying teaching it. What excites me is receiving back insights on my assignments. Paraphrasing Leonardo Da Vinci, you should never stop learning in life. The imagination of my students as they contemplate the applications and fusion of emerging technologies in society and security is an inspiration.

Sources:

1) The New Techno-fusion by Chuck Brooks

2)Human Brain/Cloud Interface

3) Emerging Bio-Science and Health Security Implications for Biometrics by Chuck Brooks

4) Researchers turn bacterial cell into biological computer

Read more from the original source:
The Merging Of Human And Machine. Two Frontiers Of Emerging Technologies - Forbes

Cell Biology

Genetic mutations may be linked to infertility, early menopause – Washington University School of Medicine in St. Louis

Visit the News Hub

Gene in fruit flies, worms, zebrafish, mice and people may help explain some fertility issues

Researchers at Washington University School of Medicine in St. Louis have identified a gene that plays an important role in fertility across multiple species. Pictured is a normal fruit fly ovary (left) and a fruit fly ovary with this gene dialed down (right). Male and female animals missing this gene had substantially defective reproductive organs. The study could have implications for understanding human infertility and early menopause.

A new study from Washington University School of Medicine in St. Louis identifies a specific genes previously unknown role in fertility. When the gene is missing in fruit flies, roundworms, zebrafish and mice, the animals are infertile or lose their fertility unusually early but appear otherwise healthy. Analyzing genetic data in people, the researchers found an association between mutations in this gene and early menopause.

The study appears Aug. 28 in the journal Science Advances.

The human gene called nuclear envelope membrane protein 1 (NEMP1) is not widely studied. In animals, mutations in the equivalent gene had been linked to impaired eye development in frogs.

The researchers who made the new discovery were not trying to study fertility at all. Rather, they were using genetic techniques to find genes involved with eye development in the early embryos of fruit flies.

We blocked some gene expression in fruit flies but found that their eyes were fine, said senior author Helen McNeill, PhD, the Larry J. Shapiro and Carol-Ann Uetake-Shapiro Professor and a BJC Investigator at the School of Medicine. So, we started trying to figure out what other problems these animals might have. They appeared healthy, but to our surprise, it turned out they were completely sterile. We found they had substantially defective reproductive organs.

Though it varied a bit by species, males and females both had fertility problems when missing this gene. And in females, the researchers found that the envelope that contains the eggs nucleus the vital compartment that holds half of an organisms chromosomes looked like a floppy balloon.

This gene is expressed throughout the body, but we didnt see this floppy balloon structure in the nuclei of any other cells, said McNeill, also a professor of developmental biology. That was a hint wed stumbled across a gene that has a specific role in fertility. We saw the impact first in flies, but we knew the proteins are shared across species. With a group of wonderful collaborators, we also knocked this gene out in worms, zebrafish and mice. Its so exciting to see that this protein that is present in many cells throughout the body has such a specific role in fertility. Its not a huge leap to suspect it has a role in people as well.

To study this floppy balloon-like nuclear envelope, the researchers used a technique called atomic force microscopy to poke a needle into the cells, first penetrating the outer membrane and then the nucleuss membrane. The amount of force required to penetrate the membranes gives scientists a measure of their stiffness. While the outer membrane was of normal stiffness, the nucleuss membrane was much softer.

Its interesting to ask whether stiffness of the nuclear envelope of the egg is also important for fertility in people, McNeill said. We know there are variants in this gene associated with early menopause. And when we studied this defect in mice, we see that their ovaries have lost the pool of egg cells that theyre born with, which determines fertility over the lifespan. So, this finding provides a potential explanation for why women with mutations in this gene might have early menopause. When you lose your stock of eggs, you go into menopause.

On the left is a normal fruit fly ovary with hundreds of developing eggs. On the right is a fruit fly ovary that is totally missing the NEMP gene. It is poorly developed and no eggs are visible.

McNeill and her colleagues suspect that the nuclear envelope has to find a balance between being pliant enough to allow the chromosomes to align as they should for reproductive purposes but stiff enough to protect them from the ovarys stressful environment. With age, ovaries develop strands of collagen with potential to create mechanical stress not present in embryonic ovaries.

If you have a softer nucleus, maybe it cant handle that environment, McNeill said. This could be the cue that triggers the death of eggs. We dont know yet, but were planning studies to address this question.

Over the course of these studies, McNeill said they found only one other problem with the mice missing this specific gene: They were anemic, meaning they lacked red blood cells.

Normal adult red blood cells lack a nucleus, McNeill said. Theres a stage when the nuclear envelope has to condense and get expelled from the young red blood cell as it develops in the bone marrow. The red blood cells in these mice arent doing this properly and die at this stage. With a floppy nuclear envelope, we think young red blood cells are not surviving in another mechanically stressful situation.

The researchers would like to investigate whether women with fertility problems have mutations in NEMP1. To help establish whether such a link is causal, they have developed human embryonic stem cells that, using CRISPR gene-editing technology, were given specific mutations in NEMP1 listed in genetic databases as associated with infertility.

We can direct these stem cells to become eggs and see what effect these mutations have on the nuclear envelope, McNeill said. Its possible there are perfectly healthy women walking around who lack the NEMP protein. If this proves to cause infertility, at the very least this knowledge could offer an explanation. If it turns out that women who lack NEMP are infertile, more research must be done before we could start asking if there are ways to fix these mutations restore NEMP, for example, or find some other way to support nuclear envelope stiffness.

This work was supported by the Canadian Institutes of Health, research grant numbers 143319, MOP-42462, PJT-148658, 153128, 156081, MOP-102546, MOP-130437, 143301, and 167279. This work also was supported, in part, by the Krembil Foundation; the Canada Research Chair program; the National Institutes of Health (NIH), grant number R01 GM100756; and NSERC Discovery grant; and the Medical Research Council, unit programme MC_UU_12015/2. Financial support also was provided by the Wellcome Senior Research Fellowship, number 095209; Core funding 092076 to the Wellcome Centre for Cell Biology; a Wellcome studentship; the Ontario Research FundsResearch Excellence Program. Proteomics work was performed at the Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, a facility supported by Canada Foundation for Innovation funding, by the Ontarian Government, and by the Genome Canada and Ontario Genomics, grant numbers OGI-097 and OGI-139.

Tsatskis Y, et al. The NEMP family supports metazoan fertility and nuclear envelope stiffness. Science Advances. Aug. 28, 2020.

Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

See more here:
Genetic mutations may be linked to infertility, early menopause - Washington University School of Medicine in St. Louis

Cell Biology

Study may help develop new types of non-addictive pain therapies – News-Medical.Net

A team of scientists from ASU's School of Molecular Sciences and the Biodesign Institute have recently published a study in Nature Communications that helps clarify the contributions to an ion channel's temperature - dependent activation. This in turn should aid in the development of new types of non-addictive pain therapies.

The ability to sense and respond to temperature is fundamental in biology. Ion channels are formed by membrane proteins that allow ions to pass through the otherwise impermeable lipid cell membrane, where they are used as a communication network.

TRPV1 is an ion channel that is widely expressed in various tissues and plays a variety of roles in biology. It is best known for its role as the primary hot sensor in humans; it is the main way that we sense heat in our environment."

Wade Van Horn, Professor and Senior Author, School of Molecular Sciences and the Biodesign Institute, Arizona State University

Although important contributions have been made in the investigation of TRPV1 thermosensing, its mechanism has remained elusive.

TRPV1 is also a common taste and pain sensor, think spicy foods and pepper spray. Beyond these roles, it has been implicated in longevity, inflammation, obesity, and cancer. For decades it has been a target in the search for new types of pain medication, ones that are not addictive.

"However, to date, a common feature is that while TRPV1 targeting compounds can relieve pain, they also cause off-target effects, especially causing changes in body temperature, which has limited their utility. These off-target effects happen because TRPV1 is activated by many distinct stimuli, including ligands (i.e., capsaicin - the main ingredient in pepper spray), heat, and protons (acidic pH)," says Van Horn.

Also particularly limiting, is the uncertainty about the mechanisms that underlie temperature-sensing and how the different activation mechanisms are linked together.

This study used a variety of techniques, from cellular to atomic in nature, to investigate the domain of TRPV1 that is key to its ligand activation.

The techniques included Nuclear Magnetic Resonance spectroscopy experiments (like an MRI) aided by Brian Cherry (Associate Research Professional in the Magnetic Resonance Research Center), intrinsic fluorescence carried out in SMS associate professor Marcia Levitus' lab.

Levitus is also part of the Biodesign Center for Single Molecule Biophysics. Other techniques included far ultraviolet circular dichroism and temperature dependent electrophysiology.

Van Horn explains that this work identifies for the first time, both functionally and thermodynamically, that a particular region (of TRPV1) is crucial to heat activation. The team proposes, and provides experimental validation for, the heat activation mechanism and details a number of structural changes that happen as the temperature is changed.

This study provides a framework that the team anticipates will be foundational for future studies to further refine how we sense high temperatures and, importantly, how we can distinguish and target specific activation mechanisms that should promote the development of new types of non-addictive pain therapies.

See original here:
Study may help develop new types of non-addictive pain therapies - News-Medical.Net

Biochemistry

Itaconic Acid Market with Competitive Analysis, New Business Developments and Top Companies: Kehai Biochemistry, Guoguang Biochemistry – The Daily…

Itaconic Acid Industry Analysis 2020

TheItaconic Acid Marketreport enlightens its readers about its products, applications, and specifications. The research enlists key companies operating in the market and also highlights the roadmap adopted by the companies to consolidate their position in the market.By extensive usage of SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and combination of key companies are comprehensively deduced and referenced in the report.Every single leading player in this global market is profiled with their related details such as product types, business overview, sales, manufacturing base, applications, and other specifications.Itaconic Acid is a naturally occurring unsaturated 5-C dicarboxylic acid which is also known as methylenesuccinic acid or methylenebutanedioic acidCurrently, the largest applications for itaconic acid are Plasticizer, accounting for 56.10% ofMajor Market Players Covered In This Report:, Kehai Biochemistry, Guoguang Biochemistry, Huaming Biochemistry, Alpha Chemika, Zhongshun Science & Technology,

Click Here To Access The Sample Report:https://grandviewreport.com/sample/17428

Covid-19 pandemic affects most industries in the globe. Here at Grand View Report we offer you comprehensive data of related industry which will help and support your business in all possible ways.

Itaconic AcidMarket has exhibited continuous growth in the recent past and is projected to grow even more throughout the forecast. The analysis presents an exhaustive assessment of the market and comprises Future trends, Current Growth Factors, attentive opinions, facts, historical information, in addition to statistically supported and trade validated market information.

The Global Itaconic AcidMarket Can Be Segmented As

The key product type of Itaconic Acidmarket are:, Synthesis, Fermentation,

Itaconic AcidMarket Outlook by Applications:, Plasticizer, Lubricating Oil Additive, Other

To Get This Report At Beneficial Rates:https://grandviewreport.com/discount/17428

The Itaconic Acidmarket comprising of well-established international vendors is giving heavy competition to new players in the market as they struggle with technological development, reliability and quality problems the analysis report examines the expansion, market size, key segments, trade share, application, and key drivers.

Key players within the Itaconic Acidmarket are identified through secondary analysis, and their market shares are determined through primary and secondary analysis. The report encloses a basic summary of the trade lifecycle, definitions, classifications, applications, and trade chain structure. Each of these factors can facilitate leading players to perceive the scope of the Market, what unique characteristics it offers and the manner in which it will fulfill a customers need.

By Company Profile, Product Image and Specification, Product Application Analysis, Production Capability, Price Cost, Production Value, Contact Data are included in this research report.

What Itaconic AcidMarket report offers:Itaconic AcidMarket share assessments for the regional and country-level segmentsMarket share analysis of the highest trade playersItaconic AcidMarket Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)Strategic recommendations on key business segments

The Report Answers Following Questions:Over successive few years, which Itaconic Acidapplication segment can perform well?Within which market, the businesses ought to establish a presence?Which product segments are exhibiting growth?What are the market restraints which are likely to impede the growth rate?However, market share changes their values by completely different producing brands?

To Know More About The Assumptions in This Market Report:http://grandviewreport.com/industry-growth/Itaconic-Acid-Market-17428

The report entails detailed profiling of each company, and information on capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments, are also included within the scope of the report. In the end, the Itaconic AcidMarket Report delivers a conclusion which includes Breakdown and Data Triangulation, Consumer Needs/Customer Preference Change, Research Findings, Market Size Estimation, Data Source. These factors are expected to augment the overall business growth.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, Europe.

Go here to see the original:
Itaconic Acid Market with Competitive Analysis, New Business Developments and Top Companies: Kehai Biochemistry, Guoguang Biochemistry - The Daily...

Biochemistry

The Road to a COVID-19 Vaccine and Treatment: a Biochemistry Student Explains – The Whit Online

In just five months, a nonliving particle one hundredth the diameter of a human hair has claimed the lives of more U.S. citizens than the Vietnam and Korean wars combined. This particle is, of course, the novel coronavirus known as COVID-19. Can scientists and medical professionals find a way to stop it before it reaps further destruction?

With the ability to switch from a nonliving to a living state after hijacking a host cells replication machinery, viruses are intricate rogue proteins that occupy a mysterious realm between biochemistry and quantum mechanics. You cannot kill viruses as they are not even alive in the first place, and the field of biochemistry is currently not advanced enough to annihilate all of these sub-microscopic parasites outright without harming you, too. However, viruses utilize a variety of chemicals to accomplish their replication cycles, and it is these specific chemicals that are vulnerable to attack.

Possible treatments for viruses are classified into one of two groups: drugs that inhibit viral replication and drugs that modify your immune response.

To understand how antiviral drugs work, you must know the substances involved in viral replication. COVID-19, aka SARS-CoV-2 (severe acute respiratory system coronavirus 2), is a single-stranded RNA virus that enters your cells by binding to a specific receptor on their surfaces, triggering endocytosis (cell entry). The virus reverse transcribes its RNA into double-stranded DNA, the blueprint for protein synthesis, using an enzyme called RNA polymerase. This enzyme lacks a proofreading function, so the resulting DNA code will mutate over time. When COVID-19s completed DNA is integrated into your cells genome, your cell exhausts its own resources manufacturing more viruses.

The viruses escape and infect other cells, eventually killing them.

Remdesivir is the most promising antiviral drug to date, and is the only one authorized by the U.S. Food and Drug Administration for emergency use. Its molecular structure mimics that of adenine, a nucleic acid in DNA. When the viruses RNA polymerase mistakenly adds a Remdesivir molecule in place of adenine, the reverse transcription process is stopped. The drugs developer, Gilead, applied for FDA approval Aug. 10 for regular use after presenting preliminary evidence proving the drugs effectiveness. Remdesivir is not a cure for COVID-19; according to the study, treatment only reduces the recovery time of infected patients and does not protect against death. FDA approval is currently pending.

Why prioritize usage of drugs when you could just prevent people from contracting COVID-19 in the first place?

This is where drugs that modify your immune response vaccines come into play. Vaccination is the best way to drastically reduce COVID-19 transmission and to grant immunity to the general public. Antibodies are protective proteins naturally synthesized by your body whenever antigens (foreign substances) invade it. By introducing a weakened form of the virus or a portion of the viruses protein structure into your body, vaccines train your immune system to manufacture its own antibodies in a phenomenon known as active immunity. When you are infected with the actual virus, your immune system swiftly identifies the pathogens protein pattern, induces apoptosis (cell death) in all affected cells, and stops viral spread in its tracks.

Unfortunately, vaccine development is a long and arduous process often riddled with complications, and rushing the development process can sacrifice drug effectiveness and even trigger dangerous immune reactions in patients. To be deemed safe and effective, immunological response data from thousands of testing subjects from specific populations (especially those with underlying health issues and senior citizens) must be compiled and analyzed. This procedure alone can take months or even years. After a vaccine is considered safe and effective, there is the additional hurdle of manufacturing and distributing the vaccine to the entire population.

The rate of vaccine development is progressing at historically fast speeds. According to Johns Hopkins Coronavirus Resource Center, the first COVID-19 vaccine was developed for testing just six weeks after the viral sequence was decoded. In comparison, the vaccine for Influenza another RNA virus infecting the respiratory system took 20 years to be developed and 26 years to be approved. In fact, by the time regular citizens were inoculated with this flu vaccine, it was ineffective because the virus had mutated by then.

The most promising SARS-CoV-2 vaccine, Moderna, entered its final phase of testing among 30,000 patients on July 27. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, has predicted that researchers will be able to determine Modernas effectiveness by November or December this year, perhaps sooner. The vaccine does its job by transmitting mRNA (messenger RNA) molecules transcribed from DNA to your cells genomes, which causes them to assemble portions of COVID-19 proteins. By introducing these inactive foreign proteins into your body, the vaccine compels your immune system to manufacture antibodies that will identify and eliminate the actual virus. The introduction of a vaccine to the American public would finally allow our country to regain some semblance of normalcy.

The way each person responds to SARS-CoV-2 infection depends on individual genetics, age and pre-existing health conditions. Some patients are not even aware of infection, while others exhibit life-threatening symptoms. COVID-19 enters cells by binding a receptor called the angiotensin enzyme converting 2 (ACE2) receptor. Angiotensin 2 is a powerful enzyme that causes your blood pressure levels to skyrocket and is implicated in inflammation in a way that is still not fully understood. For some, SARS-CoV-2 wreaks havoc on the cardiovascular system, which then damages vascularized organs requiring a constant blood supply. Despite having a 3-4% mortality rate, evidence suggests that COVID-19 is capable of inflicting lasting damage on highly vascularized organs including the lungs and brain.

Scientific advancement is not based on a couple of scientific studies or published papers. Instead, it is founded upon decades of research. Medical professionals, scientists and governments across the globe are engaged in a race unlike any other in history to develop a safe and effective vaccine, and we have learned about COVID-19 faster than any infectious disease in history.

Unanswered questions, however maddening they may be, are powerful catalysts for scientific advancement. As we expand the breadth and depth of our knowledge, not only will we have more answers, but we will have a better understanding of the right questions to ask. To quote Douglas Adams, author of The Hitchhikers Guide to the Galaxy, Phrasing the right question is much harder than finding the right answer.

Ultimately, it is questions not answers that are the driving force behind the growth of humanitys collective intelligence and the development of a successful vaccine.

Special thanks to Johns Hopkins University & Medicine Coronavirus Resource Center and RowanSOM Family Medicine Department.

For comments/questions about this story, email editor@thewhitonline.com or tweet @TheWhitOnline.

Related

Follow this link:
The Road to a COVID-19 Vaccine and Treatment: a Biochemistry Student Explains - The Whit Online

Biochemistry

Automatic Biochemistry Analyzers Market Steady Growth to Be Witnessed by 2020-2029 – Scientect

In this report, the global Automatic Biochemistry Analyzers market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.

The Automatic Biochemistry Analyzers market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the Automatic Biochemistry Analyzers market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Request Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2637505&source=atm

The major players profiled in this Automatic Biochemistry Analyzers market report include:

Market Segment AnalysisThe research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by TypeFloor-standingBench-top

Segment by ApplicationPrimary HospitalProvincial HospitalPrefectural Hospital

Global Automatic Biochemistry Analyzers Market: Regional AnalysisThe report offers in-depth assessment of the growth and other aspects of the Automatic Biochemistry Analyzers market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Automatic Biochemistry Analyzers Market: Competitive LandscapeThis section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2637505&licType=S&source=atm

The study objectives of Automatic Biochemistry Analyzers Market Report are:

To analyze and research the Automatic Biochemistry Analyzers market status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the Automatic Biochemistry Analyzers manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions Automatic Biochemistry Analyzers market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Automatic Biochemistry Analyzers market.

Make An EnquiryAbout This Report @ https://www.marketresearchhub.com/enquiry.php?type=E&repid=2637505&source=atm

The rest is here:
Automatic Biochemistry Analyzers Market Steady Growth to Be Witnessed by 2020-2029 - Scientect

Biochemistry

o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical…

Courant Market Research Reports added Latest Research Report titled Global o Aminoanisole Market Status and Trend Report 2015-2025 to its research database. This report gives detailed survey of the market by examining changing aggressive elements of the o Aminoanisole Market. It helps in understanding the key product sectors and their future. It gives pin point analysis of changing rivalry flow and keeps you in front of contenders.

Request Free Sample Report of o Aminoanisole Market Report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Our Free Complimentary Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

It offers a forward looking point of view on various elements driving or limiting business sector development. It gives a forecast based on how the market is anticipated to develop. Their key financials, general organization review, weighted SWOT examination, key advancements, developments, land spread, and procedures are contemplated and have been skillfully made in this far reaching o Aminoanisole Market report.

The o Aminoanisole Market report covers a top to bottom focused scene in which key players are profiled. Different producers engaged with the o Aminoanisole Market are surveyed. Research report for o Aminoanisole Market incorporates a worldwide viewpoint. This report investigates o Aminoanisole Market based on its market fragments, chief geologies, and current market patterns. This can bolster the user in settling on educated choices and major key systems.

Download Free PDF Report Brochure @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

This can bolster the user in settling on educated choices and major key systems. The beat of the market is unveiled in this sector which can enable the user in applying key strategies to attain competitive benefit. Such a top to bottom, far reaching research survey conveys the genuinely necessary esteem expansion, with unbiased measurable analysis and key suggestions, which can be utilized to design future extensions and enhance current position in the o Aminoanisole Market in a specific area.

Imperative areas all over the globe are secured and the patterns, advancements, drivers, restrictions, and difficulties affecting the development of the o Aminoanisole Market over these vital regions are considered. An evaluation of the effect of government strategies and holistic on the market processes is likewise included to give an all encompassing outline of the o Aminoanisole Market future viewpoint.

Inquire more about this report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Browse Full Report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs.

Originally posted here:
o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical...

Biochemistry

Chitin and Chitin Derivatives Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026 |…

LOS ANGELES, United States:The report titled Global Chitin and Chitin Derivatives Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Chitin and Chitin Derivatives market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Chitin and Chitin Derivatives market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Chitin and Chitin Derivatives market is carefully analyzed and researched about by the market analysts.The market analysts and researchers have done extensive analysis of the global Chitin and Chitin Derivatives market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Chitin and Chitin Derivatives report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/2106508/global-and-united-states-chitin-and-chitin-derivatives-market

In addition, market revenues based on region and country are provided in the Chitin and Chitin Derivatives report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global Chitin and Chitin Derivatives market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Chitin and Chitin Derivatives market are mapped by the report. With the help of this report, the key players of the global Chitin and Chitin Derivatives market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Chitin and Chitin Derivatives market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Chitin and Chitin Derivatives market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned in the Global Chitin and Chitin Derivatives Market Research Report: Agratech, ADVANCED BIOPOLYMERS, Novamatrix, Bioline, Golden Shell, Primex, Haixin, Haizhiyuan, Yunzhou, Hecreat, Bannawach Bio-Line, Hubei Huashan, Jiangsu Shuanglin Marine Biological, Golden-Shell Pharmaceutical, Zhejiang New Fuda Ocean Biotech, Weifang Haizhiyuan Biological, Ningbo Zhenhai Haixin Biological, Jinlong, Fengrun Biochemical, Qingdao Yunzhou Biochemistry

Chitin and Chitin Derivatives Market Types: Food GradeIndustrial Grade

Chitin and Chitin Derivatives Market Applications: AgricultureIndustrialMedicineOthers

The Chitin and Chitin Derivatives Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Chitin and Chitin Derivatives market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Chitin and Chitin Derivatives market and its potential to grow in the years to come.

Key questions answered in the report:

Request for customization in Report: https://www.qyresearch.com/customize-request/form/2106508/global-and-united-states-chitin-and-chitin-derivatives-market

Table of Contents:

1 Study Coverage1.1 Chitin and Chitin Derivatives Product Introduction1.2 Market Segments1.3 Key Chitin and Chitin Derivatives Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global Chitin and Chitin Derivatives Market Size Growth Rate by Type1.4.2 Food Grade1.4.3 Industrial Grade1.5 Market by Application1.5.1 Global Chitin and Chitin Derivatives Market Size Growth Rate by Application1.5.2 Agriculture1.5.3 Industrial1.5.4 Medicine1.5.5 Others1.6 Study Objectives1.7 Years Considered

2 Executive Summary2.1 Global Chitin and Chitin Derivatives Market Size, Estimates and Forecasts2.1.1 Global Chitin and Chitin Derivatives Revenue 2015-20262.1.2 Global Chitin and Chitin Derivatives Sales 2015-20262.2 Global Chitin and Chitin Derivatives, Market Size by Producing Regions: 2015 VS 2020 VS 20262.3 Chitin and Chitin Derivatives Historical Market Size by Region (2015-2020)2.3.1 Global Chitin and Chitin Derivatives Retrospective Market Scenario in Sales by Region: 2015-20202.3.2 Global Chitin and Chitin Derivatives Retrospective Market Scenario in Revenue by Region: 2015-20202.4 Chitin and Chitin Derivatives Market Estimates and Projections by Region (2021-2026)2.4.1 Global Chitin and Chitin Derivatives Sales Forecast by Region (2021-2026)2.4.2 Global Chitin and Chitin Derivatives Revenue Forecast by Region (2021-2026)

3 Global Chitin and Chitin Derivatives Competitor Landscape by Players3.1 Global Top Chitin and Chitin Derivatives Sales by Manufacturers3.1.1 Global Chitin and Chitin Derivatives Sales by Manufacturers (2015-2020)3.1.2 Global Chitin and Chitin Derivatives Sales Market Share by Manufacturers (2015-2020)3.2 Global Chitin and Chitin Derivatives Manufacturers by Revenue3.2.1 Global Chitin and Chitin Derivatives Revenue by Manufacturers (2015-2020)3.2.2 Global Chitin and Chitin Derivatives Revenue Share by Manufacturers (2015-2020)3.2.3 Global Chitin and Chitin Derivatives Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Chitin and Chitin Derivatives Revenue in 20193.2.5 Global Chitin and Chitin Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Global Chitin and Chitin Derivatives Price by Manufacturers3.4 Global Chitin and Chitin Derivatives Manufacturing Base Distribution, Product Types3.4.1 Chitin and Chitin Derivatives Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Chitin and Chitin Derivatives Product Type3.4.3 Date of International Manufacturers Enter into Chitin and Chitin Derivatives Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)4.1 Global Chitin and Chitin Derivatives Market Size by Type (2015-2020)4.1.1 Global Chitin and Chitin Derivatives Sales by Type (2015-2020)4.1.2 Global Chitin and Chitin Derivatives Revenue by Type (2015-2020)4.1.3 Chitin and Chitin Derivatives Average Selling Price (ASP) by Type (2015-2026)4.2 Global Chitin and Chitin Derivatives Market Size Forecast by Type (2021-2026)4.2.1 Global Chitin and Chitin Derivatives Sales Forecast by Type (2021-2026)4.2.2 Global Chitin and Chitin Derivatives Revenue Forecast by Type (2021-2026)4.2.3 Chitin and Chitin Derivatives Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Chitin and Chitin Derivatives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)5.1 Global Chitin and Chitin Derivatives Market Size by Application (2015-2020)5.1.1 Global Chitin and Chitin Derivatives Sales by Application (2015-2020)5.1.2 Global Chitin and Chitin Derivatives Revenue by Application (2015-2020)5.1.3 Chitin and Chitin Derivatives Price by Application (2015-2020)5.2 Chitin and Chitin Derivatives Market Size Forecast by Application (2021-2026)5.2.1 Global Chitin and Chitin Derivatives Sales Forecast by Application (2021-2026)5.2.2 Global Chitin and Chitin Derivatives Revenue Forecast by Application (2021-2026)5.2.3 Global Chitin and Chitin Derivatives Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application6.1 United States Chitin and Chitin Derivatives Market Size YoY Growth 2015-20266.1.1 United States Chitin and Chitin Derivatives Sales YoY Growth 2015-20266.1.2 United States Chitin and Chitin Derivatives Revenue YoY Growth 2015-20266.1.3 United States Chitin and Chitin Derivatives Market Share in Global Market 2015-20266.2 United States Chitin and Chitin Derivatives Market Size by Players (International and Local Players)6.2.1 United States Top Chitin and Chitin Derivatives Players by Sales (2015-2020)6.2.2 United States Top Chitin and Chitin Derivatives Players by Revenue (2015-2020)6.3 United States Chitin and Chitin Derivatives Historic Market Review by Type (2015-2020)6.3.1 United States Chitin and Chitin Derivatives Sales Market Share by Type (2015-2020)6.3.2 United States Chitin and Chitin Derivatives Revenue Market Share by Type (2015-2020)6.3.3 United States Chitin and Chitin Derivatives Price by Type (2015-2020)6.4 United States Chitin and Chitin Derivatives Market Estimates and Forecasts by Type (2021-2026)6.4.1 United States Chitin and Chitin Derivatives Sales Forecast by Type (2021-2026)6.4.2 United States Chitin and Chitin Derivatives Revenue Forecast by Type (2021-2026)6.4.3 United States Chitin and Chitin Derivatives Price Forecast by Type (2021-2026)6.5 United States Chitin and Chitin Derivatives Historic Market Review by Application (2015-2020)6.5.1 United States Chitin and Chitin Derivatives Sales Market Share by Application (2015-2020)6.5.2 United States Chitin and Chitin Derivatives Revenue Market Share by Application (2015-2020)6.5.3 United States Chitin and Chitin Derivatives Price by Application (2015-2020)6.6 United States Chitin and Chitin Derivatives Market Estimates and Forecasts by Application (2021-2026)6.6.1 United States Chitin and Chitin Derivatives Sales Forecast by Application (2021-2026)6.6.2 United States Chitin and Chitin Derivatives Revenue Forecast by Application (2021-2026)6.6.3 United States Chitin and Chitin Derivatives Price Forecast by Application (2021-2026)

7 North America7.1 North America Chitin and Chitin Derivatives Market Size YoY Growth 2015-20267.2 North America Chitin and Chitin Derivatives Market Facts & Figures by Country7.2.1 North America Chitin and Chitin Derivatives Sales by Country (2015-2020)7.2.2 North America Chitin and Chitin Derivatives Revenue by Country (2015-2020)7.2.3 U.S.7.2.4 Canada

8 Europe8.1 Europe Chitin and Chitin Derivatives Market Size YoY Growth 2015-20268.2 Europe Chitin and Chitin Derivatives Market Facts & Figures by Country8.2.1 Europe Chitin and Chitin Derivatives Sales by Country8.2.2 Europe Chitin and Chitin Derivatives Revenue by Country8.2.3 Germany8.2.4 France8.2.5 U.K.8.2.6 Italy8.2.7 Russia

9 Asia Pacific9.1 Asia Pacific Chitin and Chitin Derivatives Market Size YoY Growth 2015-20269.2 Asia Pacific Chitin and Chitin Derivatives Market Facts & Figures by Country9.2.1 Asia Pacific Chitin and Chitin Derivatives Sales by Region (2015-2020)9.2.2 Asia Pacific Chitin and Chitin Derivatives Revenue by Region9.2.3 China9.2.4 Japan9.2.5 South Korea9.2.6 India9.2.7 Australia9.2.8 Taiwan9.2.9 Indonesia9.2.10 Thailand9.2.11 Malaysia9.2.12 Philippines9.2.13 Vietnam

10 Latin America10.1 Latin America Chitin and Chitin Derivatives Market Size YoY Growth 2015-202610.2 Latin America Chitin and Chitin Derivatives Market Facts & Figures by Country10.2.1 Latin America Chitin and Chitin Derivatives Sales by Country10.2.2 Latin America Chitin and Chitin Derivatives Revenue by Country10.2.3 Mexico10.2.4 Brazil10.2.5 Argentina

11 Middle East and Africa11.1 Middle East and Africa Chitin and Chitin Derivatives Market Size YoY Growth 2015-202611.2 Middle East and Africa Chitin and Chitin Derivatives Market Facts & Figures by Country11.2.1 Middle East and Africa Chitin and Chitin Derivatives Sales by Country11.2.2 Middle East and Africa Chitin and Chitin Derivatives Revenue by Country11.2.3 Turkey11.2.4 Saudi Arabia11.2.5 U.A.E

12 Company Profiles12.1 Agratech12.1.1 Agratech Corporation Information12.1.2 Agratech Description and Business Overview12.1.3 Agratech Sales, Revenue and Gross Margin (2015-2020)12.1.4 Agratech Chitin and Chitin Derivatives Products Offered12.1.5 Agratech Recent Development12.2 ADVANCED BIOPOLYMERS12.2.1 ADVANCED BIOPOLYMERS Corporation Information12.2.2 ADVANCED BIOPOLYMERS Description and Business Overview12.2.3 ADVANCED BIOPOLYMERS Sales, Revenue and Gross Margin (2015-2020)12.2.4 ADVANCED BIOPOLYMERS Chitin and Chitin Derivatives Products Offered12.2.5 ADVANCED BIOPOLYMERS Recent Development12.3 Novamatrix12.3.1 Novamatrix Corporation Information12.3.2 Novamatrix Description and Business Overview12.3.3 Novamatrix Sales, Revenue and Gross Margin (2015-2020)12.3.4 Novamatrix Chitin and Chitin Derivatives Products Offered12.3.5 Novamatrix Recent Development12.4 Bioline12.4.1 Bioline Corporation Information12.4.2 Bioline Description and Business Overview12.4.3 Bioline Sales, Revenue and Gross Margin (2015-2020)12.4.4 Bioline Chitin and Chitin Derivatives Products Offered12.4.5 Bioline Recent Development12.5 Golden Shell12.5.1 Golden Shell Corporation Information12.5.2 Golden Shell Description and Business Overview12.5.3 Golden Shell Sales, Revenue and Gross Margin (2015-2020)12.5.4 Golden Shell Chitin and Chitin Derivatives Products Offered12.5.5 Golden Shell Recent Development12.6 Primex12.6.1 Primex Corporation Information12.6.2 Primex Description and Business Overview12.6.3 Primex Sales, Revenue and Gross Margin (2015-2020)12.6.4 Primex Chitin and Chitin Derivatives Products Offered12.6.5 Primex Recent Development12.7 Haixin12.7.1 Haixin Corporation Information12.7.2 Haixin Description and Business Overview12.7.3 Haixin Sales, Revenue and Gross Margin (2015-2020)12.7.4 Haixin Chitin and Chitin Derivatives Products Offered12.7.5 Haixin Recent Development12.8 Haizhiyuan12.8.1 Haizhiyuan Corporation Information12.8.2 Haizhiyuan Description and Business Overview12.8.3 Haizhiyuan Sales, Revenue and Gross Margin (2015-2020)12.8.4 Haizhiyuan Chitin and Chitin Derivatives Products Offered12.8.5 Haizhiyuan Recent Development12.9 Yunzhou12.9.1 Yunzhou Corporation Information12.9.2 Yunzhou Description and Business Overview12.9.3 Yunzhou Sales, Revenue and Gross Margin (2015-2020)12.9.4 Yunzhou Chitin and Chitin Derivatives Products Offered12.9.5 Yunzhou Recent Development12.10 Hecreat12.10.1 Hecreat Corporation Information12.10.2 Hecreat Description and Business Overview12.10.3 Hecreat Sales, Revenue and Gross Margin (2015-2020)12.10.4 Hecreat Chitin and Chitin Derivatives Products Offered12.10.5 Hecreat Recent Development12.11 Agratech12.11.1 Agratech Corporation Information12.11.2 Agratech Description and Business Overview12.11.3 Agratech Sales, Revenue and Gross Margin (2015-2020)12.11.4 Agratech Chitin and Chitin Derivatives Products Offered12.11.5 Agratech Recent Development12.12 Hubei Huashan12.12.1 Hubei Huashan Corporation Information12.12.2 Hubei Huashan Description and Business Overview12.12.3 Hubei Huashan Sales, Revenue and Gross Margin (2015-2020)12.12.4 Hubei Huashan Products Offered12.12.5 Hubei Huashan Recent Development12.13 Jiangsu Shuanglin Marine Biological12.13.1 Jiangsu Shuanglin Marine Biological Corporation Information12.13.2 Jiangsu Shuanglin Marine Biological Description and Business Overview12.13.3 Jiangsu Shuanglin Marine Biological Sales, Revenue and Gross Margin (2015-2020)12.13.4 Jiangsu Shuanglin Marine Biological Products Offered12.13.5 Jiangsu Shuanglin Marine Biological Recent Development12.14 Golden-Shell Pharmaceutical12.14.1 Golden-Shell Pharmaceutical Corporation Information12.14.2 Golden-Shell Pharmaceutical Description and Business Overview12.14.3 Golden-Shell Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)12.14.4 Golden-Shell Pharmaceutical Products Offered12.14.5 Golden-Shell Pharmaceutical Recent Development12.15 Zhejiang New Fuda Ocean Biotech12.15.1 Zhejiang New Fuda Ocean Biotech Corporation Information12.15.2 Zhejiang New Fuda Ocean Biotech Description and Business Overview12.15.3 Zhejiang New Fuda Ocean Biotech Sales, Revenue and Gross Margin (2015-2020)12.15.4 Zhejiang New Fuda Ocean Biotech Products Offered12.15.5 Zhejiang New Fuda Ocean Biotech Recent Development12.16 Weifang Haizhiyuan Biological12.16.1 Weifang Haizhiyuan Biological Corporation Information12.16.2 Weifang Haizhiyuan Biological Description and Business Overview12.16.3 Weifang Haizhiyuan Biological Sales, Revenue and Gross Margin (2015-2020)12.16.4 Weifang Haizhiyuan Biological Products Offered12.16.5 Weifang Haizhiyuan Biological Recent Development12.17 Ningbo Zhenhai Haixin Biological12.17.1 Ningbo Zhenhai Haixin Biological Corporation Information12.17.2 Ningbo Zhenhai Haixin Biological Description and Business Overview12.17.3 Ningbo Zhenhai Haixin Biological Sales, Revenue and Gross Margin (2015-2020)12.17.4 Ningbo Zhenhai Haixin Biological Products Offered12.17.5 Ningbo Zhenhai Haixin Biological Recent Development12.18 Jinlong12.18.1 Jinlong Corporation Information12.18.2 Jinlong Description and Business Overview12.18.3 Jinlong Sales, Revenue and Gross Margin (2015-2020)12.18.4 Jinlong Products Offered12.18.5 Jinlong Recent Development12.19 Fengrun Biochemical12.19.1 Fengrun Biochemical Corporation Information12.19.2 Fengrun Biochemical Description and Business Overview12.19.3 Fengrun Biochemical Sales, Revenue and Gross Margin (2015-2020)12.19.4 Fengrun Biochemical Products Offered12.19.5 Fengrun Biochemical Recent Development12.20 Qingdao Yunzhou Biochemistry12.20.1 Qingdao Yunzhou Biochemistry Corporation Information12.20.2 Qingdao Yunzhou Biochemistry Description and Business Overview12.20.3 Qingdao Yunzhou Biochemistry Sales, Revenue and Gross Margin (2015-2020)12.20.4 Qingdao Yunzhou Biochemistry Products Offered12.20.5 Qingdao Yunzhou Biochemistry Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Chitin and Chitin Derivatives Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Chitin and Chitin Derivatives Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details16.3 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

Read the original:
Chitin and Chitin Derivatives Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026 |...